Unpredictability of glaucoma progression

Current Medical Research and Opinion

Volumn 25, Issue 9, 2009, Pages 2167-2177

  Susanna Jr , Remo ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Glaucoma; Ocular hypertension; Progression; Risk factors

Indexed keywords

BLINDNESS; DISEASE COURSE; EARLY DIAGNOSIS; FOLLOW UP; GLAUCOMA; HUMAN; INTRAOCULAR HYPERTENSION; LASER SURGERY; NOTE; PATIENT MONITORING; PERIMETRY; RETINA GANGLION CELL; RETINA INJURY; TOPICAL TREATMENT; TRABECULOPLASTY; VISUAL FIELD; VISUAL IMPAIRMENT;

AGED; ANTIHYPERTENSIVE AGENTS; BLINDNESS; DISEASE PROGRESSION; GLAUCOMA; HUMANS; MIDDLE AGED; OCULAR HYPERTENSION; PROGNOSIS; TREATMENT OUTCOME; VISUAL FIELDS;

EID: 69849104836     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007990903098867     Document Type: Note

References (55)

1. Weinreb RN, Friedman DS, Fechtner RD, et al. Risk assessment in the management of patients with ocular hypertension. Am J Ophthalmol 2004;138:458-467 (Pubitemid 39208574)
2. Susanna Jr R, Vessani RM. New findings in the evaluation of the optic disc in glaucoma diagnosis. Curr Opin Ophthalmol 2007;18:122-128
3. Quigley HA, Enger C, Katz J, et al. Risk factors for the development of glaucomatous visual field loss in ocular hypertension. Arch Ophthalmol 1994;112:644-649 (Pubitemid 24155438)
4. Martus P, Stroux A, Budde WM, et al. Predictive factors for progressive optic nerve damage in various types of chronic open-angle glaucoma. Am J Ophthalmol 2005;139:999-1009 (Pubitemid 40813310)
5. Johnson CA, Sample PA, Zangwill LM, et al. Structure and function evaluation (SAFE): II. Comparison of optic disk and visual field characteristics. Am J Ophthalmol 2003;135:148-154
6. Susanna Jr R, Drance SM, Douglas GR. Disc hemorrhages in patients with elevated intraocular pressure. Occurrence with and without field changes. Arch Ophthalmol 1979;97:284-285
7. Quigley HA, Addicks EM, Green WR. Optic nerve damage in human glaucoma. III. Quantitative correlation of nerve fiber loss and visual field defect in glaucoma, ischemic neuropathy, papilledema, and toxic neuropathy. Arch Ophthalmol 1982;100:135-146
8. Harwerth RS, Carter-Dawson L, Shen F, et al. Ganglion cell losses underlying visual field defects from experimental glaucoma. Invest Ophthalmol Vis Sci 1999;40:2242-2250 (Pubitemid 29418378)
9. Harwerth R, Quigley HA. Visual field defects and retinal ganglion cell losses in patients with glaucoma. Arch Ophthalmol 2006;124:853-859 (Pubitemid 43877679)
10. Artes PH, Chauhan BC. Longitudinal changes in the visual field and optic disc in glaucoma. Prog Retin Eye Res 2005;24:333-354
11. Strouthidis NG, Scott A, Peter NM, et al. Optic disc and visual field progression in ocular hypertensive subjects: detection rates, specificity, and agreement. Invest Ophthalmol Vis Sci 2006;47:2904-2910 (Pubitemid 351639765)
12. Kerrigan-Baumrind LA, Quigley HA, Pease ME, et al. Number of ganglion cells in glaucoma eyes compared with threshold visual field tests in the same persons. Invest Ophthalmol Vis Sci 2000;41:741-748
13. Lee BB. Receptive field structure in the primate retina. Vision Res 1996;36:631-644
14. Meister M. Multineuronal codes in retinal signaling. Proc Natl Acad Sci USA 1996;93:609-614
15. Brusini P, Johnson CA. Staging functional damage in glaucoma: review of different classification methods. Surv Ophthalmol 2007;52:156-179 (Pubitemid 46367858)
16. Spry PG, Johnson CA. Identification of progressive glaucomatous visual field loss. Surv Ophthalmol 2002;47:158-173 (Pubitemid 34256411)
17. Caprioli J, Garway-Heath DF. A critical reevaluation of current glaucoma management. Ophthalmology 2007;114:S1-S41
18. Weber AJ, Chen H, Hubbard WC, et al. Experimental glaucoma and cell size, density, and number in the primate lateral geniculate nucleus. Invest Ophthalmol Vis Sci 2000;41:1370-1379 (Pubitemid 30261859)
19. Yücel YH, Zhang Q, Weinreb RN, et al. Atrophy of relay neurons in magno- and parvocellular layers in the lateral geniculate nucleus in experimental glaucoma. Invest Ophthalmol Vis Sci 2001;42:3216-3222 (Pubitemid 33740682)
20. Gupta N, Ang LC, Noël de Tilly L, et al. Human glaucoma and neural degeneration in intracranial optic nerve, lateral geniculate nucleus, and visual cortex. Br J Ophthalmol 2006;90:674-678 (Pubitemid 43835477)
21. Hodapp E, Parrish II RK, Anderson DR: Clinical Decisions in Glaucoma. St. Louis: The C.V. Mosby Co., 1993. pp. 52-61
22. Ansari I, Chauban BC, McCormick TA, et al. Comparison of conventional and pattern discrimination perimetry in a prospective study of glaucoma patients. Invest Ophthalmol Vis Sci 2000;41:4150-4157
23. Reardon G, Schwartz GF, Mozaffari E. Patient persistency with topical ocular hypotensive therapy in a managed care population. Am J Ophthalmol 2004;137:S3-S12 (Pubitemid 38091629)
24. Nordstrom BL, Friedman DS, Mozaffari E, et al. Persistence and adherence with topical glaucoma therapy. Am J Ophthalmol 2005;140:598-606 (Pubitemid 41455298)
25. Olthoff CM, Schouten JS, van de Borne BW, et al. Noncompliance with ocularhypotensive treatment in patients with glaucoma or ocular hypertension: an evidence-based review. Ophthalmology 2005;112:953-961
26. Kass MA, Heuer DK, Higginbotham EJ, et al. The Ocular Hypertension Treatment Study. A randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol 2002;120:701-713
27. Miglior S, Zeyen T, Pfeiffer N, et al. Results of the European Glaucoma Prevention Study. Ophthalmology 2005;112:366-375 (Pubitemid 40312486)
28. Collaborative Normal-Tension Glaucoma Study Group. Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Am J Ophthalmol 1998;126:487-497
29. Lichter PR, Musch DC, Gillespie BW, et al. Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery. Ophthalmology 2001;108:1943-1953
30. AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS): 12. Baseline risk factors for sustained loss of visual field and visual acuity in patients with advanced glaucoma. Am J Ophthalmol 2002;134:499-512
31. Leske MC, Heijl A, Hyman L, et al. Predicators of long-term progression in the Early Manifest Glaucoma Trial. Ophthalmology 2007;114:1965-1972 (Pubitemid 350016362)
32. Nouri-Mahdavi K, Hoffman D, Coleman AL, et al. Predictive factors for glaucomatous visual field progression in the Advanced Glaucoma Intervention Study. Ophthalmology 2004;111:1627-1635 (Pubitemid 39179673)
33. Ocular Hypertension Treatment Study Group & European Glaucoma Prevention Study Group. Validated prediction model for the development of primary open-angle glaucoma in individuals with ocular hypertension. Ophthalmology 2007;114:10-19
34. Leske MC, Heijl A, Hussein M, et al. Factors for glaucoma progression and the effect of treatment: the Early Manifest Glaucoma Trial. Arch Ophthalmol 2003;121:48-56 (Pubitemid 36401765)
35. Bengtsson B, Leske MC, Hyman L, et al. Fluctuation of intraocular pressure and glaucoma progression in the Early Manifest Glaucoma Trial. Ophthalmology 2007;114:205-209 (Pubitemid 46161799)
36. Gordon MO, Beiser JA, Brandt JD, et al. The Ocular Hypertension Treatment Study. Baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol 2002;120:714-720
37. Parrish RK 2nd. The European Glaucoma Prevention Study and the Ocular Hypertension Treatment Study: why do two studies have different results? Curr Opin Ophthalmol 2006;17:138-141
38. Heijl A, Leske MC, Bengtsson B, et al. Reduction of intraocular pressure and glaucoma progression. Results from the Early Manifest Glaucoma Trial. Arch Ophthalmol 2002;120:1268-1279
39. Mitchell P, Hourihan F, Sandbach J, et al. The relationship between glaucoma and myopia. The Blue Mountains Eye Study. Ophthalmology 1999;106:2010-2015
40. Perdicchi A, Iester M, Scuderi G, et al. Visual field damage and progression in glaucomatous myopic eyes. Eur J Ophthalmol 2007;17:534-537 (Pubitemid 47605760)
41. Mojon DS, Hess CW, Goldblum D, et al. High prevalence of glaucoma in patients with sleep apnea syndrome. Ophthalmology 1999;106:1009-1012 (Pubitemid 30191563)
42. Onen SH, Mouriaux F, Berramdane L, et al. High prevalence of sleep-disordered breathing in patients with primary open-angle glaucoma. Acta Ophthalmol Scand 2000;78:638-641
43. Mojon DS, Hess CW, Goldblum D, et al. Primary open-angle glaucoma is associated with sleep apnea syndrome. Ophthalmologica 2000;214:1115-1118 (Pubitemid 30179205)
44. Mojon DS, Hess CW, Goldblum D, et al. Normal-tension glaucoma is associated with sleep apnea syndrome. Ophthalmologica 2002;216:180-184 (Pubitemid 34639069)
45. Boland MV, Quigley HA. Risk factors and open-angle glaucoma: classification and application. J Glaucoma 2007;16:406-418 (Pubitemid 46945541)
46. Bonovas S, Peponis V, Filioussi K. Diabetes mellitus as a risk factor for primary open-angle glaucoma: a meta-analysis. Diabet Med 2004;21:609-614 (Pubitemid 38746283)
47. Pasquale LR, Kang JH, Manson JE, et al. Prospective study of type 2 diabetes mellitus and risk of primary open-angle glaucoma in women. Ophthalmology 2006;113:1081-1086 (Pubitemid 43947238)
48. Chopra V, Varma R, Francis BA, et al. Type 2 diabetes mellitus and the risk of open-angle glaucoma. The Los Angeles Latino Eye Study. Ophthalmology 2008;115:227-232
49. Caprioli J, Coleman AL. Intraocular pressure fluctuation: a risk factor for visual field progression at low intraocular pressures in the Advanced Glaucoma Intervention Study. Ophthalmology 2008;115:1123-1129
50. Herndon LW, Weizer JS, Stinnett SS. Central corneal thickness as a risk factor for advanced glaucoma damage. Arch Ophthalmol 2004;122:17-21 (Pubitemid 38063599)
51. Jonas JB, Stroux A, Velten I, et al. Central corneal thickness correlated with glaucoma damage and rate of progression. Invest Ophthalmol Vis Sci 2005;46:1269-1274 (Pubitemid 41685863)
52. Shah H, Kniestedt C, Bostrom A, et al. Role of central corneal thickness on baseline parameters and progression of visual fields in open angle glaucoma. Eur J Ophthalmol 2007;17:545-549 (Pubitemid 47605762)
53. Dueker DK, Singh K, Lin SC, et al. Corneal thickness measurement in the management of primary open-angle glaucoma: a report by the American Academy of Ophthalmology. Ophthalmology 2007;114:1779-1787 (Pubitemid 47332694)
54. American Academy of Ophthalmology. Preferred Practice Pattern. Primary Open-Angle Glaucoma. San Francisco: American Academy of Ophthalmology, 2005. pp. 1-19
55. European Glaucoma Society. Terminology and Guidelines for Glaucoma, 2nd edn. Savona: Editrice DOGMA® S.r.l., 2003. pp. 26-27